Controller Forums

Our Controller Forums

Controllers, please join us in our forum for members of the HIV Controller community — a place to share your story, talk, and make new friends! Get linked to clinical research studies and follow the adventures of our members who travel to participate in them!

To join, click "Register" at the bottom of this page and follow the instructions. You will need to have the "passphrase" from your invitation. If you are a controller and haven't received an invitation,  send us an email using the "Contact Us" link above.

Handful of 20-year HIV survivors hold key to discovering vaccine Print E-mail

Researchers are looking into the antibodies that provide natural immunity

Kai Brothers contracted HIV in the 80s, but never developed AIDS.In a desperate attempt to reverse 25 years of failure to develop an AIDS vaccine, scientists have a new approach: studying people who have been infected with HIV for many years without any signs of ill-health. The patients' secret? Natural immunity.

The researchers have investigated the virus-fighting antibodies found in the blood of six long-term survivors of HIV whose own immune systems appear to be capable of shrugging off the virus. Results of tests show that a prototype vaccine made from several of the antibodies produced by those long-term survivors can prevent HIV from infecting human cells. The experiments have been successful on human cells growing in a test tube. Now further trials are planned on laboratory animals and human volunteers.

The search for an AIDS vaccine has suffered a series of setbacks over the years. The most recent was the failure of the most promising potential vaccine, in a major clinical trial by the US drug company Merck. The trial, which had involved thousands of volunteers, had to be abandoned at the end of 2007 because of fears that the trial vaccine might in fact make patients more susceptible to AIDS.

Read more...
 
Antibodies Present in Long-Term HIV Survivors Could Contribute to Vaccine Development, Study Says Print E-mail
HIV-positive people who do not develop AIDS and do not require antiretroviral medication could provide insight for new strategies in vaccine development, according to a study published Sunday in the journal Nature, London's Independent reports. Michel Nussenzweig — head of Rockefeller University's Laboratory of Molecular Immunology and author of the study — said his research aimed to harness natural mechanisms to target HIV rather than use synthetically produced antibodies, some of which have failed in earlier HIV vaccine trials.
Read more...
 
<< Start < Prev 1 2 Next > End >>